Associate Scientist III, Metabolic Diseases

$120k - $129k

Workplace
Hybrid
Employment
Full-time

About this role

Associate Scientist III, Metabolic Diseases, wanted by Insitro, Inc. in South San Francisco, CA. Engineer complex 3D cell models (spheroids and co-cultures) using various cell types for mechanistic studies; Develop and qualify workflows to validate drug targets, define mechanism of action and conduct pharmacology studies for drug discovery using techniques such as CRISPR, siRNA and RNAseq; Independently develop and optimize in vitro assays by leveraging molecular biology techniques, advanced microscopy and automated instrumentation for metabolic disease phenotyping; Generate datasets from ex vivo samples for key efficacy and target engagement readouts to enable critical go/no-go decisions; Analyze high-throughput datasets using sophisticated Machine Learning-based pipelines; Lead small projects end-to-end and coordinate handoffs between multi-disciplinary teams to meet key project milestones; Generate presentations and publication material for effective scientific communication at the company level; Adhere to good lab practices and document all experimental parameters meticulously in an Electronic Lab Notebook (ELN) for data integrity.

Must have a Master’s degree in Biotechnology, Bioengineering or a related field plus two (2) years of experience in a related occupation. In lieu of a Master’s degree plus two (2) years of experience, we will accept a Bachelor’s degree in Biotechnology, Bioengineering or a related field plus five (5) years of progressive experience in a related occupation. Must have two (2) years of experience handling primary, immortalized, and iPSC-derived cell lines (such as hepatocytes, fibroblasts and endothelial cells) and engineering complex disease models including co-cultures and spheroids; two (2) years of experience executing high throughput screening such as pooled optical, arrayed CRISPR screens and siRNA drug discovery screens; two (2) years of experience handling tool compounds such as oligonucleotides, small molecules and antibodies for functional validation, disease phenotyping, and mechanistic studies; two (2) years of experience applying molecular biology techniques for gene expression such as qPCR and RNAseq; and protein expression such as Jess, MSD, and Luminex; two (2) years of experience developing pharmacology and drug discovery assays, and establishing qualification metrics (Z’, % CV, IC50 and reproducibility); two (2) years of experience leveraging advanced microscopy, high-content imaging, and analysis using Machine Learning-based image segmentation pipelines; two (2) years of experience with large-scale processing of ex-vivo tissues (liver, fat or pancreas) for downstream assays; two (2) years of experience handling state of the art automation instrumentation such as Agilent Bravo, Hamilton STAR, ECHO and Multidrop combi; two (2) years of experience with using LIMS and other lab oriented software such as GraphPad Prism (data analysis) and Benchling (Electronic Lab Notebook)

$120,349-$129,000/yr. Please send resume to: [email protected] and refer to: Job Req._2026-insitro-005P____.

insitro is an equal opportunity employer. All applicants will be considered for employment without attention to race, color, religion, sex, sexual orientation, gender identity, national origin, veteran or disability status.

We believe diversity, equity, and inclusion need to be at the foundation of our culture. We work hard to bring together diverse teams–grounded in a wide range of expertise and life experiences–and work even harder to ensure those teams thrive in inclusive, growth-oriented environments supported by equitable company and team practices. All candidates can expect equitable treatment, respect, and fairness throughout the interview process.

#LI-Hybrid

Please be aware of recruitment scams: we never request payments, all recruitment communications are from @insitro.com, and if in doubt, contact us at [email protected].

About insitro

insitro is a drug discovery and development company using machine learning (ML) and data at scale to decode biology for transformative medicines. At the core of insitro’s approach is the convergence of in-house generated multi-modal cellular data and high-content phenotypic human cohort data. We rely on these data to develop ML-driven, predictive disease models that uncover underlying biologic state and elucidate critical drivers of disease. These powerful models rely on extensive biological and computational infrastructure and allow insitro to advance novel targets and patient biomarkers, design therapeutics and inform clinical strategy. insitro is advancing a wholly owned and partnered pipeline of insights and therapeutics in neuroscience and metabolism. Since launching in 2018, insitro has raised over $700 million from top tech, biotech and crossover investors, and from collaborations with pharmaceutical partners. For more information on insitro, please visit www.insitro.com.

Apply to insitro

Clera fills in insitro's application for you.

How it works

Open the role in Clera

Sign in, and this role opens on your Clera job board, ready to apply.

Clera fills in the application

Clera fills the form from your profile and resume, and asks what's missing.

Track it in Clera

Each application you send shows up in your Clera tracker, sorted by stage.

Want Clera to find roles for you?

Ask your AI about this role

It knows you. Clera gives it the role.

Does this role fit my profile?

First time? Connect Clera once, about a minute.
One click above pre-fills the connector. Or by hand: Settings > Connectors > Add custom connector, paste https://mcp.getclera.com. Either way, sign in with the account you use on Clera and approve the consent screen.
https://mcp.getclera.com

Sign in with your Clera account. MCP docs

About insitro

insitro is the physical AI company unlocking causal human biology, founded and led by AI pioneer Daphne Koller. By generating the world’s largest integrated multi-modal corpus of human and cellular data, we’ve built the Virtual Human™ – a genetically anchored causal AI engine that reveals how disease begins, progresses, and can be resolved. Our platform enables us to precisely identify causal genetic drivers and deploy our TherML™ AI platform to design optimal medicines, advancing a broad pipeline of therapeutics for neuroscience and metabolic diseases. This industrialized architecture creates a self-learning loop: with every biology we onboard, our predictive models grow smarter, accelerating discovery across scales of biology.

Join us in transforming the future of medicine!

Team size
201-500 employees people
Founded
2018
Industry
Artificial Intelligence
Workplace
Hybrid
Locations
South San Francisco, California, United States